Familial chylomicronemia syndrome in children: a diagnosis challenge
- PMID: 36506766
- PMCID: PMC9732601
- DOI: 10.21037/tp-22-515
Familial chylomicronemia syndrome in children: a diagnosis challenge
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-22-515/coif). MJA reports that she received personal payments once for consulting services from Akcea in 2020 and for a presentation in 2021 from the European Atherosclerosis Society. PV reports that he received honoraria as a speaker from Sanofi, Amgen, Amarin, Akcea, Daiichi-Sankyo, Servier, as advisor from Sanofi, Amgen, Amarin, Akcea, Daiichi-Sankyo, a grant from Sanofi and support to travel from Daiichi-Sankyo, Servier, Sanofi, Amgen, Sobi, PTC. The authors have no other conflicts of interest to declare.
Comment on
-
Novel pathogenic variant combination in LPL causing familial chylomicronemia syndrome in an Asian family and experimental validation in vitro: a case report.Transl Pediatr. 2022 Oct;11(10):1717-1725. doi: 10.21037/tp-22-15. Transl Pediatr. 2022. PMID: 36345447 Free PMC article.